 | | G8D | | 表記: | [(2R,3S,4R,5R)-5-[2-azanyl-6,8-bis(oxidanylidene)-1,7-dihydropurin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl phosphono
hydrogen phosphate | | 組成式: | C10 H15 N5 O12 P2 | | SMILES: | NC1=NC2=C(NC(=O)N2[CH]3O[CH](CO[P](O)(=O)O[P](O)(O)=O)[CH](O)[CH]3O)C(=O)N1 | | InChi: | InChI=1S/C10H15N5O12P2/c11-9-13-6-3(7(18)14-9)12-10(19)15(6)8-5(17)4(16)2(26-8)1-25-29(23,24)27-28(20,21)22/h2,4-5,8,16-17H,1H2,(H,12,19)(H,23,24)(H2,20,21,22)(H3,11,13,14,18)/t2-,4-,5-,8-/m1/s1 | | 別名: | 8-oxoguanosine-5'-diphosphate | | 定義日: | 2016-06-17 | | 最終更新日: | 2020-06-17 | | 公開日: | 2017-04-19 | | 識別子（ID）: | [(2~{R},3~{S},4~{R},5~{R})-5-[2-azanyl-6,8-bis(oxidanylidene)-1,7-dihydropurin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl phosphono hydrogen phosphate |
|
 | | WAA | | 表記: | (2S)-2-[[(1R,4aR,4bR,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthren-1-yl]carbonylamino]-3-(
1H-indol-3-yl)propanoic acid | | 組成式: | C31 H40 N2 O3 | | SMILES: | CC(C)C1=CC2=CC[CH]3[C](C)(CCC[C]3(C)C(=O)N[CH](Cc4c[nH]c5ccccc45)C(O)=O)[CH]2CC1 | | InChi: | InChI=1S/C31H40N2O3/c1-19(2)20-10-12-24-21(16-20)11-13-27-30(24,3)14-7-15-31(27,4)29(36)33-26(28(34)35)17-22-18-32-25-9-6-5-8-23(22)25/h5-6,8-9,11,16,18-19,24,26-27,32H,7,10,12-15,17H2,1-4H3,(H,33,36)(H,34,35)/t24-,26-,27+,30+,31+/m0/s1 | | 別名: | N-Abietoyl-L-Tryptophan | | 定義日: | 2019-03-15 | | 最終更新日: | 2020-06-17 | | 公開日: | 2020-03-18 | | 識別子（ID）: | (2~{S})-2-[[(1~{R},4~{a}~{R},4~{b}~{R},10~{a}~{R})-1,4~{a}-dimethyl-7-propan-2-yl-2,3,4,4~{b},5,6,10,10~{a}-octahydrophenanthren-1-yl]carbonylamino]-3-(1~{H}-indol-3-yl)propanoic acid |
|
 | | G93 | | 表記: | 4-{2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-piperidin-3-ylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl}-2-methylbut-3
-yn-2-ol | | 組成式: | C21 H27 N7 O3 | | SMILES: | n1onc(N)c1c2nc4c(n2CC)c(OCC3CCCNC3)cnc4C#CC(O)(C)C | | InChi: | InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-5-9-23-10-13)11-24-14(7-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4-6,9-10,12H2,1-3H3,(H2,22,27)/t13-/m0/s1 | | 別名: | GSK690693 | | 定義日: | 2008-05-08 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | 4-{2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-piperidin-3-ylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl}-2-methylbut-3-yn-2-ol |
|
 | | G97 | | 表記: | N-[2-phenyl-4-(1H-pyrazol-3-ylamino)quinazolin-7-yl]prop-2-enamide | | 組成式: | C20 H16 N6 O | | SMILES: | O=C(C=C)Nc2ccc1c(nc(nc1c2)c3ccccc3)Nc4nncc4 | | InChi: | InChI=1S/C20H16N6O/c1-2-18(27)22-14-8-9-15-16(12-14)23-19(13-6-4-3-5-7-13)25-20(15)24-17-10-11-21-26-17/h2-12H,1H2,(H,22,27)(H2,21,23,24,25,26) | | 別名: | N-(4-(1H-pyrazol-3-ylamino)-2-phenylquinazolin-7-yl)acrylamide | | 定義日: | 2009-06-16 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | N-[2-phenyl-4-(1H-pyrazol-3-ylamino)quinazolin-7-yl]prop-2-enamide |
|
 | | G9F | | 表記: | 2-{4-[3-(dimethylamino)propoxy]phenyl}-5,6-dihydroimidazo[4,5,1-jk][1,4]benzodiazepin-7(4H)-one | | 組成式: | C21 H24 N4 O2 | | SMILES: | CN(C)CCCOc1ccc(cc1)c2nc3cccc4C(=O)NCCn2c34 | | InChi: | InChI=1S/C21H24N4O2/c1-24(2)12-4-14-27-16-9-7-15(8-10-16)20-23-18-6-3-5-17-19(18)25(20)13-11-22-21(17)26/h3,5-10H,4,11-14H2,1-2H3,(H,22,26) | | 別名: | 1-[4-(3-Dimethylamino-propoxy)-phenyl]-8,9-dihydro-7H-2,7,9a-triaza-benzo[cd]azulen-6 | | 定義日: | 2009-11-03 | | 最終更新日: | 2020-06-17 |
|
 | | G9H | | 表記: | 2-[(dimethylamino)methyl]-5,6-dihydroimidazo[4,5,1-jk][1,4]benzodiazepin-7(4H)-one | | 組成式: | C13 H16 N4 O | | SMILES: | CN(C)Cc1nc2cccc3C(=O)NCCn1c23 | | InChi: | InChI=1S/C13H16N4O/c1-16(2)8-11-15-10-5-3-4-9-12(10)17(11)7-6-14-13(9)18/h3-5H,6-8H2,1-2H3,(H,14,18) | | 別名: | 1-Dimethylaminomethyl-8,9-dihydro-7H-2,7,9a-triaza-benzo[cd]azulen-6-one | | 定義日: | 2009-11-03 | | 最終更新日: | 2020-06-17 |
|
 | | G9P | | 表記: | (11bR)-3-oxo-1,2,3,11b-tetrahydrochromeno[4,3,2-de]isoquinoline-10-sulfonic acid | | 組成式: | C15 H11 N O5 S | | SMILES: | O[S](=O)(=O)c1ccc2Oc3cccc4C(=O)NC[CH](c2c1)c34 | | InChi: | InChI=1S/C15H11NO5S/c17-15-9-2-1-3-13-14(9)11(7-16-15)10-6-8(22(18,19)20)4-5-12(10)21-13/h1-6,11H,7H2,(H,16,17)(H,18,19,20)/t11-/m1/s1 | | 別名: | 1,11b-Dihydro-[1]benzopyrano[4,3,2-de]isoquinolin-3(2H)-one-10-sulphonic acid | | 定義日: | 2009-11-03 | | 最終更新日: | 2020-06-17 |
|
 | | GA0 | | 表記: | GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE | | 組成式: | C20 H24 N4 O3 | | SMILES: | O=C(Nc2cc1ccccc1cc2)C3N(C(=O)C(NC(=O)CN)C)CCC3 | | InChi: | InChI=1S/C20H24N4O3/c1-13(22-18(25)12-21)20(27)24-10-4-7-17(24)19(26)23-16-9-8-14-5-2-3-6-15(14)11-16/h2-3,5-6,8-9,11,13,17H,4,7,10,12,21H2,1H3,(H,22,25)(H,23,26)/t13-,17-/m0/s1 | | 別名: | GLYCYL-ALANYL-PROLINE-BETA-NAPHTHYLAMIDE | | 定義日: | 2006-01-16 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | glycyl-L-alanyl-N-naphthalen-2-yl-L-prolinamide |
|
 | | GA3 | | 表記: | GIBBERELLIN A3 | | 組成式: | C19 H22 O6 | | SMILES: | O=C(O)C5C21CC(O)(C(=C)C1)CCC2C34OC(=O)C(C)(C(O)C=C3)C45 | | InChi: | InChI=1S/C19H22O6/c1-9-7-17-8-18(9,24)5-3-10(17)19-6-4-11(20)16(2,15(23)25-19)13(19)12(17)14(21)22/h4,6,10-13,20,24H,1,3,5,7-8H2,2H3,(H,21,22)/t10-,11+,12-,13-,16-,17+,18+,19-/m1/s1 | | 別名: | (1S,2S,4aR,4bR,7S,9aS,10S,10aR)-2,7-dihydroxy-1-methyl-8-methylidene-13-oxo-1,2,4b,5,6,7,8,9,10,10a-decahydro-4a,1-(epo
xymethano)-7,9a-methanobenzo[a]azulene-10-carboxylic acid | | 定義日: | 2008-09-04 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | (1S,2S,4aR,4bR,7S,9aS,10S,10aR)-2,7-dihydroxy-1-methyl-8-methylidene-13-oxo-1,2,4b,5,6,7,8,9,10,10a-decahydro-4a,1-(epoxymethano)-7,9a-methanobenzo[a]azulene-10-carboxylic acid |
|
 | | GAJ | | 表記: | N-TETRAZOL-5-YL 9-OXO-9H-XANTHENE-2 SULPHONAMIDE | | 組成式: | C14 H9 N5 O4 S | | SMILES: | O=S(=O)(/N=C1/NN=NN1)c3cc2C(=O)c4c(Oc2cc3)cccc4 | | InChi: | InChI=1S/C14H9N5O4S/c20-13-9-3-1-2-4-11(9)23-12-6-5-8(7-10(12)13)24(21,22)17-14-15-18-19-16-14/h1-7H,(H2,15,16,17,18,19) | | 別名: | N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE | | 定義日: | 2005-10-24 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | N-(1,4-dihydro-5H-tetrazol-5-ylidene)-9-oxo-9H-xanthene-2-sulfonamide |
|
 | | GC2 | | 表記: | 6-ACETAMIDO-6-DEOXY-CASTANOSPERMINE | | 組成式: | C10 H18 N2 O4 | | SMILES: | O=C(NC2C(O)C(O)C1N(CCC1O)C2)C | | InChi: | InChI=1S/C10H18N2O4/c1-5(13)11-6-4-12-3-2-7(14)8(12)10(16)9(6)15/h6-10,14-16H,2-4H2,1H3,(H,11,13)/t6-,7-,8+,9+,10+/m0/s1 | | 別名: | N-[(1S,6S,7R,8R,8AR)-1,7,8-TRIHYDROXYOCTAHYDROINDOLIZIN-6-YL]ACETAMIDE | | 定義日: | 2010-07-02 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | N-[(1S,6S,7R,8R,8aR)-1,7,8-trihydroxyoctahydroindolizin-6-yl]acetamide |
|
 | | GCG | | 表記: | BIS(GAMMA-GLUTAMYL-CYSTEINYL-GLYCINYL)SPERMIDINE | | 組成式: | C27 H49 N9 O10 S2 | | SMILES: | O=C(NCC(=O)NCCCNCCCCNC(=O)CNC(=O)C(NC(=O)CCC(C(=O)O)N)CS)C(NC(=O)CCC(C(=O)O)N)CS | | InChi: | InChI=1S/C27H49N9O10S2/c28-16(26(43)44)4-6-20(37)35-18(14-47)24(41)33-12-22(39)31-10-2-1-8-30-9-3-11-32-23(40)13-34-25(42)19(15-48)36-21(38)7-5-17(29)27(45)46/h16-19,30,47-48H,1-15,28-29H2,(H,31,39)(H,32,40)(H,33,41)(H,34,42)(H,35,37)(H,36,38)(H,43,44)(H,45,46)/t16-,17-,18-,19-/m0/s1 | | 別名: | TRYPANOTHIONE | | 定義日: | 1999-07-08 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | (2S,7R,26R,31S)-2,31-diamino-5,8,11,22,25,28-hexaoxo-7,26-bis(sulfanylmethyl)-6,9,12,16,21,24,27-heptaazadotriacontane-1,32-dioic acid (non-preferred name) |
|
 | | GCH | | 表記: | GLYCOCHOLIC ACID | | 組成式: | C26 H43 N O6 | | SMILES: | O=C(O)CNC(=O)CCC(C3CCC2C1C(O)CC4CC(O)CCC4(C)C1CC(O)C23C)C | | InChi: | InChI=1S/C26H43NO6/c1-14(4-7-22(31)27-13-23(32)33)17-5-6-18-24-19(12-21(30)26(17,18)3)25(2)9-8-16(28)10-15(25)11-20(24)29/h14-21,24,28-30H,4-13H2,1-3H3,(H,27,31)(H,32,33)/t14-,15+,16-,17-,18+,19+,20-,21+,24+,25+,26-/m1/s1 | | 別名: | N-CHOLYLGLYCINE | | 定義日: | 2000-03-09 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | N-[(3beta,5beta,7beta,9beta,12beta)-3,7,12-trihydroxy-24-oxocholan-24-yl]glycine |
|
 | | GCQ | | 表記: | GEMCITABINE DIPHOSPHATE | | 組成式: | C9 H13 F2 N3 O10 P2 | | SMILES: | O=P(O)(O)OP(=O)(O)OCC2OC(N1C(=O)N=C(N)C=C1)C(F)(F)C2O | | InChi: | InChI=1S/C9H13F2N3O10P2/c10-9(11)6(15)4(3-22-26(20,21)24-25(17,18)19)23-7(9)14-2-1-5(12)13-8(14)16/h1-2,4,6-7,15H,3H2,(H,20,21)(H2,12,13,16)(H2,17,18,19)/t4-,6-,7-/m1/s1 | | 別名: | ((2R,3R,5R)-5-(4-AMINO-2-OXOPYRIMIDIN-1(2H)-YL)-4,4-DIFLUORO-3-HYDROXYTETRAHYDROFURAN-2-YL)METHYL TRIHYDROGEN
DIPHOSPHATE | | 定義日: | 2005-11-22 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | 2'-deoxy-2',2'-difluorocytidine 5'-(trihydrogen diphosphate) |
|
 | | GCY | | 表記: | N-[(2S,3R)-1-(beta-D-galactopyranosyloxy)-3-hydroxyoctadec-4-en-2-yl]tetracosanamide | | 組成式: | C48 H93 N O8 | | SMILES: | O=C(NC(COC1OC(C(O)C(O)C1O)CO)C(O)/C=C/CCCCCCCCCCCCC)CCCCCCCCCCCCCCCCCCCCCCC | | InChi: | InChI=1S/C48H93NO8/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-26-28-30-32-34-36-38-44(52)49-41(40-56-48-47(55)46(54)45(53)43(39-50)57-48)42(51)37-35-33-31-29-27-25-16-14-12-10-8-6-4-2/h35,37,41-43,45-48,50-51,53-55H,3-34,36,38-40H2,1-2H3,(H,49,52)/b37-35+/t41-,42+,43+,45-,46-,47+,48+/m0/s1 | | 別名: | beta-Galactosylceramide, Ceramide beta-D-galactoside | | 定義日: | 2011-08-25 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | N-[(2S,3R,4E)-1-(beta-D-galactopyranosyloxy)-3-hydroxyoctadec-4-en-2-yl]tetracosanamide |
|
 | | GDG | | 表記: | GDP-ALPHA-D-GLUCOSE | | 組成式: | C16 H25 N5 O16 P2 | | SMILES: | C1(C(O)C(C(C(O1)CO)O)O)OP(OP(OCC4C(C(C(n2cnc3c2NC(=NC3=O)N)O4)O)O)(O)=O)(O)=O | | InChi: | InChI=1S/C16H25N5O16P2/c17-16-19-12-6(13(28)20-16)18-3-21(12)14-10(26)8(24)5(34-14)2-33-38(29,30)37-39(31,32)36-15-11(27)9(25)7(23)4(1-22)35-15/h3-5,7-11,14-15,22-27H,1-2H2,(H,29,30)(H,31,32)(H3,17,19,20,28)/t4-,5-,7-,8-,9+,10-,11-,14-,15-/m1/s1 | | 別名: | GDP-ALPHA-D-GLUCOSE | | 定義日: | 2006-09-05 | | 最終更新日: | 2020-06-17 | | 公開日: | 2017-06-21 | | 識別子（ID）: | [(2R,3S,4R,5R)-5-(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl dihydrogen diphosphate (non-preferred name) |
|
 | | GDT | | 表記: | (2E,4E)-N-[(2S,3R)-3-hydroxy-1-[[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino]-1-ox
obutan-2-yl]dodeca-2,4-dienamide | | 組成式: | C27 H44 N4 O6 | | SMILES: | O=C(C=CC=CCCCCCCC)NC(C(=O)NC1C(=O)NC(C=CC(=O)NCCC(O)C1)C)C(O)C | | InChi: | InChI=1S/C27H44N4O6/c1-4-5-6-7-8-9-10-11-12-13-24(35)31-25(20(3)32)27(37)30-22-18-21(33)16-17-28-23(34)15-14-19(2)29-26(22)36/h10-15,19-22,25,32-33H,4-9,16-18H2,1-3H3,(H,28,34)(H,29,36)(H,30,37)(H,31,35)/b11-10+,13-12+,15-14+/t19-,20+,21-,22-,25-/m0/s1 | | 別名: | Glidobactin A | | 定義日: | 2007-11-20 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | (2E,4E)-N-[(1S,2R)-2-hydroxy-1-{[(3E,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]carbamoyl}propyl]dodeca-2,4-dienamide |
|
 | | GEK | | 表記: | (2S)-4-[{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl}(carboxylatomethyl)sulfonio]
-2-ammoniobutanoate | | 組成式: | C16 H22 N6 O7 S | | SMILES: | [O-]C(=O)C[S+](CCC(C([O-])=O)[NH3+])CC3OC(n2cnc1c(ncnc12)N)C(O)C3O | | InChi: | InChI=1S/C16H22N6O7S/c17-7(16(27)28)1-2-30(4-9(23)24)3-8-11(25)12(26)15(29-8)22-6-21-10-13(18)19-5-20-14(10)22/h5-8,11-12,15,25-26H,1-4,17H2,(H3-,18,19,20,23,24,27,28)/t7-,8+,11+,12+,15+,30-/m0/s1 | | 別名: | CARBOXY-S-ADENOSYLMETHIONINE | | 定義日: | 2012-08-29 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | (2S)-4-[{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl}(carboxylatomethyl)sulfonio]-2-ammoniobutanoate |
|
 | | GEM | | 表記: | (2-GUANIDINOETHYLMERCAPTO)SUCCINIC ACID | | 組成式: | C7 H13 N3 O4 S | | SMILES: | O=C(O)C(SCCNC(=[N@H])N)CC(=O)O | | InChi: | InChI=1S/C7H13N3O4S/c8-7(9)10-1-2-15-4(6(13)14)3-5(11)12/h4H,1-3H2,(H,11,12)(H,13,14)(H4,8,9,10)/t4-/m0/s1 | | 別名: | 2-GUANIDINOETHYLTHIO)SUCCINIC ACID | | 定義日: | 2001-02-12 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | (2S)-2-[(2-carbamimidamidoethyl)sulfanyl]butanedioic acid |
|
 | | GEN | | 表記: | GENISTEIN | | 組成式: | C15 H10 O5 | | SMILES: | O=C1c3c(OC=C1c2ccc(O)cc2)cc(O)cc3O | | InChi: | InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)11-7-20-13-6-10(17)5-12(18)14(13)15(11)19/h1-7,16-18H | | 別名: | 5,7-DIHYDROXY-3-(4-HYDROXYPHENYL)-4H-1-BENZOPYRAN-4-ONE | | 定義日: | 1999-07-28 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | 5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one |
|
 | | GEO | | 表記: | GEMCITABINE | | 組成式: | C9 H11 F2 N3 O4 | | SMILES: | O=C1N=C(N)C=CN1C2OC(C(O)C2(F)F)CO | | InChi: | InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1 | | 別名: | 2',2'-DIFLUORODEOXYCYTIDINE | | 定義日: | 2003-04-29 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | 2'-deoxy-2',2'-difluorocytidine |
|
 | | IY1 | | 表記: | 5-methyl-1-(4-nitrophenyl)-2-oxo-2,5-dihydro-1H-pyrido[3,2-b]indole-3-carbonitrile | | 組成式: | C19 H12 N4 O3 | | SMILES: | N#CC=2C(=O)N(c1ccc(cc1)[N+](=O)[O-])c3c(C=2)n(C)c4c3cccc4 | | InChi: | InChI=1S/C19H12N4O3/c1-21-16-5-3-2-4-15(16)18-17(21)10-12(11-20)19(24)22(18)13-6-8-14(9-7-13)23(25)26/h2-10H,1H3 | | 別名: | Indopy-1 | | 定義日: | 2019-03-14 | | 最終更新日: | 2020-06-17 | | 公開日: | 2019-10-23 | | 識別子（ID）: | 5-methyl-1-(4-nitrophenyl)-2-oxo-2,5-dihydro-1H-pyrido[3,2-b]indole-3-carbonitrile |
|
 | | IYT | | 表記: | N-ALPHA-ACETYL-3,5-DIIODOTYROSYL-D-THREONINE | | 組成式: | C15 H18 I2 N2 O6 | | SMILES: | Ic1cc(cc(I)c1O)CC(C(=O)NC(C(=O)O)C(O)C)NC(=O)C | | InChi: | InChI=1S/C15H18I2N2O6/c1-6(20)12(15(24)25)19-14(23)11(18-7(2)21)5-8-3-9(16)13(22)10(17)4-8/h3-4,6,11-12,20,22H,5H2,1-2H3,(H,18,21)(H,19,23)(H,24,25)/t6-,11+,12-/m1/s1 | | 別名: | THREONINE DERIVATIVE | | 定義日: | 2004-03-03 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | N-acetyl-3,5-diiodo-L-tyrosyl-D-allothreonine |
|
 | | IZN | | 表記: | (4bS,6S)-6-methoxy-1,4,6,7,9,10,12,13-octahydro-3H,5H-pyrano[4',3':3,4]pyrido[2,1-i]indol-3-one | | 組成式: | C16 H21 N O3 | | SMILES: | O=C1OCC3=C(C1)C42C(=CCC(OC)C2)CCN4CC3 | | InChi: | InChI=1S/C16H21NO3/c1-19-13-3-2-12-5-7-17-6-4-11-10-20-15(18)8-14(11)16(12,17)9-13/h2,13H,3-10H2,1H3/t13-,16-/m0/s1 | | 別名: | (2S,13bS)-2-Methoxy-2,3,5,6,8,9,10,13-octahydro-1H,12H-benzo[i]pyrano[3,4-g]indolizin-12-one | | 定義日: | 2012-03-06 | | 最終更新日: | 2020-06-17 | | 公開日: | 2012-08-24 | | 識別子（ID）: | (4bS,6S)-6-methoxy-1,4,6,7,9,10,12,13-octahydro-3H,5H-pyrano[4',3':3,4]pyrido[2,1-i]indol-3-one |
|
 | | J01 | | 表記: | (2R,3Z,5R)-3-(2-HYDROXYETHYLIDENE)-7-OXO-4-OXA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID | | 組成式: | C8 H9 N O5 | | SMILES: | O=C2N1C(C(/OC1C2)=C/CO)C(=O)O | | InChi: | InChI=1S/C8H9NO5/c10-2-1-4-7(8(12)13)9-5(11)3-6(9)14-4/h1,6-7,10H,2-3H2,(H,12,13)/b4-1-/t6-,7-/m1/s1 | | 別名: | CLAVULANIC ACID | | 定義日: | 2006-11-29 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | (2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
|
